Travere Therapeutics (TVTX) is up 9.5%, or $2.89 to $33.33.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVTX:
- Travere Therapeutics price target lowered to $41 from $44 at JPMorgan
- Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics
- Travere Therapeutics Earnings Call Shows Growth Amid Risks
- Travere Therapeutics: Buy Rating Anchored by Filspari’s 2026 FSGS Catalyst and Supported by IgAN Franchise Strength
- Travere Therapeutics, Inc. (TVTX) Q4 Earnings Cheat Sheet